Company · CIK 2019410
Caris Life Sciences, Inc.
| CIK | 2019410 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 8071 — Services-Medical Laboratories |
| Incorporated in | TX |
| Business address | TX |
| Listed | CAI (Nasdaq) |
| First annual or quarterly report | 2025-08-12 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-287551 | 2025-05-23 | 2025-06-20 | 5 |
Filings
6| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-06-20 | 424B4Final prospectus | 333-287551 | 0001104659-25-060762 |
| 2025-06-17 | EFFECTDeclared effective | 333-287551 | 9999999995-25-001946 |
| 2025-06-16 | S-1/AAmendment | 333-287551 | 0001104659-25-059635 |
| 2025-06-09 | S-1/AAmendment | 333-287551 | 0001104659-25-057593 |
| 2025-05-23 | S-1Registration filed | 333-287551 | 0001104659-25-052381 |
| 2024-06-10 | DRSDraft made public | 377-07265 | 0001104659-24-069897 |